Agios Pharmaceuticals
AGIO
Reported
Thursday, October 31
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 1.11 | 16.2 | 15.1 | 1361.26% |
| Revenue | 9.46M | 8.96M | -496K | -5.24% |
WhatIF - Earnings
EPS Beat Expectations by $15.11
Agios Pharmaceuticals (AGIO:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything